Golden State Equity Partners »

Aurinia Pharmaceuticals shares owned by Golden State Equity Partners

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Golden State Equity Partners from 13F filings

Historical chart of Golden State Equity Partners investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Golden State Equity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Golden State Equity Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.6k 900 7.33

More positions owned by Golden State Equity Partners

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Harbor Etf Trust Long Term Grower (WINN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Harbor Etf Trust Long Term Grower (WINN)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
First Tr Exchange-traded Smid Risng Etf (SDVY)
First Tr Exch Traded Fd Iii Horizon Dmst Etf (HUSV)
salesforce (CRM)

View all positions for Golden State Equity Partners

Top funds holding Aurinia Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Tang Capital Management
NEA Management Company
State Street Corporation
Goldman Sachs Group
Nuveen Asset Management
Geode Capital Management
Vanguard Group
Rock Springs Capital Management
Susquehanna International
Citadel Advisors
Schroder Investment Management Group
Northern Trust

View all funds holding Aurinia Pharmaceuticals